Andere Sprachen 4basebio PLC

Aktien

Verzögert London S.E. Andere Börsenplätze 13:27:45 30.04.2024			% 5 Tage	% 1. Jan.
1’100 ^GBX	+2.80%		+5.26%	+61.76%

10.04.	4basebio liefert synthetische DNA für mRNA-Impfstoffprogramm	AN
10.04.	4Basebio plc kündigt die Lieferung seiner opDNA? DNA-Produkte an das Impfstoffprogramm eines Tier 1 Pharma-Kunden	CI

4basebio to supply synthetic DNA for mRNA vaccine program	10.04.
4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program	10.04.
4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	10.04.
4basebio updates markets on "key milestone" with client	21.03.
4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine	21.03.
Alpha Real Trust says in "robust" financial shape	01.03.
4basebio wins DNA supply contract to support RNA therapies	01.03.
4basebio Wins Synthetic DNA Supply Tender from CPI	01.03.
4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence	01.03.
4basebio Plc - Holding(s) in Company	06.02.
4basebio Plc - Holding(s) in Company	06.02.
4basebio Plc - Holding(s) in Company	06.02.
4basebio Plc - Holding(s) in Company	06.02.
4basebio Plc - Exercise of Options	06.02.
4basebio Plc - Holding(s) in Company	05.02.
4basebio Plc - Holding(s) in Company	05.02.
4basebio Plc - Holding(s) in Company	05.02.
4basebio Plc - Directors' Dealings	05.02.
4basebio Plc - Long-Term Incentive Plan and Exercise of Options	02.02.
4basebio interim loss widens as research costs increase	21.09.23

Keine Ergebnisse zu dieser Suche